Skip to main
CI

Cigna (CI) Stock Forecast & Price Target

Cigna (CI) Analyst Ratings

Based on 17 analyst ratings
Buy
Strong Buy 29%
Buy 47%
Hold 24%
Sell 0%
Strong Sell 0%

Bulls say

Cigna Group is well-positioned to continue their positive growth trajectory with strong performance across all segments, including a 100% economics pass-through structure for their NCI line. Management's proactive decision to exit the exchange market and strategic review of EviCore demonstrates their commitment to driving long-term value for shareholders. With strong leadership, diverse board and workforce, and a solid corporate responsibility platform, Cigna is set to continue its success in the healthcare industry.

Bears say

Cigna Group is expected to have solid performance in its CVS selling season, which should increase overall retention rates and drive new business wins. However, the company's 2026 MLR guidance remains unchanged, indicating potential risks for higher medical costs. Even with a solid start to the 2027 PBS selling season, there are still uncertainties surrounding the company's potential for future growth, particularly with regards to its specialty drug capabilities and exposure to government headwinds.

Cigna (CI) has been analyzed by 17 analysts, with a consensus rating of Buy. 29% of analysts recommend a Strong Buy, 47% recommend Buy, 24% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Cigna and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Cigna (CI) Forecast

Analysts have given Cigna (CI) a Buy based on their latest research and market trends.

According to 17 analysts, Cigna (CI) has a Buy consensus rating as of Aug 29, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $342.88, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $342.88, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Cigna (CI)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.